Clorox (CLX)
(Delayed Data from NYSE)
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike
by Zacks Equity Research
Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.
UL or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Clorox (CLX) Down 6% in 6 Months: Can Efforts Aid Recovery?
by Zacks Equity Research
Clorox (CLX) is grappling with elevated commodity costs, adverse currency rates as well as increased manufacturing and logistics expenses. Nevertheless, the company is on track with its 2020 Strategy.
Clorox (CLX) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of -2.04% and -0.79%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Q3 Earnings & Sales Miss Estimates, Stock Down
by Zacks Equity Research
Clorox's (CLX) top and bottom lines missed the Zacks Consensus Estimate in third-quarter fiscal 2019. The company narrows its guidance for fiscal 2019.
Can Clorox (CLX) Keep the Earnings Beat Streak Alive in Q3?
by Zacks Equity Research
Clorox (CLX) gains from smooth progress on its 2020 Strategy, focus on e-commerce growth and brand-management initiatives.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UL or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
UL vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Clorox (CLX) Thriving on 2020 Strategy & Digital Efforts
by Zacks Equity Research
Clorox (CLX) gains from smooth progress on 2020 Strategy, focus on e-commerce and brand-management initiatives. It also has a robust earnings surprise history.
UL vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Colgate (CL) Enhances Shareholder Returns, Hikes Dividend
by Zacks Equity Research
Colgate (CL) increases quarterly dividend from 42 cents per share to 43 cents. The company is also progressing well with the Global Growth and Efficiency Program.
Procter & Gamble Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Procter & Gamble (PG) gains from its solid focus on product improvement, packaging and marketing initiatives, and productivity and cost-savings plan.
Here's Why Investors Should Buy Clorox (CLX) Stock Right Now
by Zacks Equity Research
Clorox (CLX) gains from strategic initiatives including smooth execution of the 2020 Strategy, focus on e-commerce business and brand management efforts.
Clorox (CLX) Up 2.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can Soap & Cleaning Materials Industry Players Balance Costs & Growth?
by Zacks Equity Research
The FMCG space continues its struggles against higher raw material and transportation costs. Meanwhile, product innovation, marketing initiatives and restructuring actions should aid growth.
UN vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?
Company News For Feb 5, 2019
by Zacks Equity Research
Companies In The News Are: PZZA,ULTI,CLX,SYY
Clorox (CLX) Jumps: Stock Rises 5.7%
by Zacks Equity Research
Clorox (CLX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Google Earnings Preview & Today's Trending Tickers: PZZA, TSLA, CLX
by Ryan McQueeney
Ryan McQueeney discusses news involving Papa John's, Tesla, Clorox, and Sysco. Later, he previews Alphabet's upcoming earnings announcement and explains what investors should watch for in the internet giant's report.
Economic & Earnings Data Deluge
by Zacks Equity Research
Economic & Earnings Data Deluge
Q4 Earnings Soldier on Gamely: GOOGL, CLX & More
by Mark Vickery
Eearnings reports to this point, based on strong consumer confidence and historically robust employment data (see Friday's 300K+ new jobs created last month), have been surprisingly positive amid these various and unpredictable headwinds.
Clorox (CLX) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Clorox (CLX) retains forecasts for fiscal 2019, which should benefit from ongoing cost-savings plans.
Clorox (CLX) Beats Q2 Earnings Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 6.06% and -0.40%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
UN vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?